Browse > Article
http://dx.doi.org/10.4070/kcj.2016.46.4.468

Pre-Treatment with Statins for Coronary Intervention: Pleiotropy of Statins or Effect of LDL-cholesterol Reduction?  

Habon, Tamas (1st Department of Medicine, Division of Cardiology, University of Pecs, Medical Center)
Toth, Kalman (1st Department of Medicine, Division of Cardiology, University of Pecs, Medical Center)
Publication Information
Korean Circulation Journal / v.46, no.4, 2016 , pp. 468-471 More about this Journal
Keywords
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Wang CY, Liu PY, Liao JK. Pleiotropic effects of statin therapy: molecular mechanisms and clinical results. Trends Mol Med 2008;14:37-44.   DOI
2 Rosenson RS. Statin therapy: new therapy for cardiac microvascular dysfunction. Eur Heart J 2003;24:1993-4.   DOI
3 Szapary L, Horvath B, Marton Z, et al. Short-term effect of low-dose atorvastatin on haemorrheological parameters, platelet aggregation and endothelial function in patients with cerebrovascular disease and hyperlipidaemia. CNS Drugs 2004;18:165-72.   DOI
4 Eisen A, Leshem-Lev D, Yavin H, et al. Effect of High Dose Statin Pretreatment on Endothelial Progenitor Cells After Percutaneous Coronary Intervention (HIPOCRATES Study). Cardiovasc Drugs Ther 2015;29:129-35.   DOI
5 Lee BK, Koo BK, Nam CW, et al. Does pretreatment with high dose atorvastatin prevent microvascular dysfunction after percutaneous coronary intervention in patients with acute coronary syndrome? Korean Circ J 2016;46:472-80.   DOI
6 Pasceri V, Patti G, Nusca A, Pristipino C, Richichi G, Di Sciascio G: ARMYDA Investigators. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of Myocardial Damage during Angioplasty) study. Circulation 2004;110:674-8.   DOI
7 Briguori C, Visconti G, Focaccio A, et al. Novel approaches for preventing or limiting events (NAPLES) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction. J Am Coll Cardiol 2009;54:2157-63.   DOI
8 Fearon WF, Balsam LB, Farouque HM, et al. Novel index for invasively assessing the coronary microcirculation. Circulation 2003;107:3129-32.   DOI
9 Fujii K, Kawasaki D, Oka K, et al. The impact of pravastatin pretreatment on periprocedural microcirculatory damage in patients undergoing percutaneous coronary intervention. JACC Cardiovasc Interv 2011;4:513-20.   DOI
10 Eagle KA, Chopra V. Statins before coronary procedures a new indication for an old friend. J Am Coll Cardiol 2010;56:1110-2.   DOI
11 Tamai O, Matsuoka H, Itabe H, Wada Y, Kohno K, Imaizumi T. Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation 1997;95:76-82.   DOI
12 Jarcho JA, Keaney JF Jr. Proof that lower is better--LDL cholesterol and IMPROVE-IT. N Engl J Med 2015;372:2448-50.   DOI